# Megestrol Acetate Plus Rosuvastatin in Young Women With Early Endometrial Carcinoma

> **NCT04491643** · PHASE2 · COMPLETED · sponsor: **Fudan University** · enrollment: 48 (actual)

## Conditions studied

- Endometrial Carcinoma Stage I

## Interventions

- **DRUG:** Megestrol Acetate
- **DRUG:** Rosuvastatin

## Key facts

- **NCT ID:** NCT04491643
- **Lead sponsor:** Fudan University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-09-01
- **Primary completion:** 2023-08-11
- **Final completion:** 2025-04-11
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2025-08-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04491643

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04491643, "Megestrol Acetate Plus Rosuvastatin in Young Women With Early Endometrial Carcinoma". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT04491643. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*